SoloVital: Drug Recall
Recall #D-0620-2024 · 07/12/2024
Class I: Dangerous
Recall Details
- Recall Number
- D-0620-2024
- Classification
- Class I
- Product Type
- Drug
- Recalling Firm
- SoloVital
- Status
- Ongoing
- Date Initiated
- 07/12/2024
- Location
- Chula Vista, CA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,331 bottles
Reason for Recall
Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.
Product Description
Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.
Distribution Pattern
Nationwide within the United States
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.